Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2014 Filed Feb 25, 2014 22:13 UTC |
DeVos Georges H.Senior Vice President
|
GrantOption (right to buy) · Derivative | 81,940 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003624 · edgar.xml · derivative · entry 1 DeVos Georges H. · CIK 0001580246 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,940 Underlying: Common shares · 81,940 shares Expires 2024-02-20 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,314 on 2/21/2015, 27,313 on 2/21/2016, and 27,313 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:18 UTC |
Fussell Stephen RExecutive Vice President
|
GrantOption (right to buy) · Derivative | 134,741 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003626 · edgar.xml · derivative · entry 4 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,741 Underlying: Common Shares · 134,741 shares Expires 2024-02-20 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 44,914 on 2/21/2015, 44,913 on 2/21/2016, and 44,914 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:18 UTC |
Fussell Stephen RExecutive Vice President
|
GrantCommon Shares without par value | 22,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003626 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,178 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:19 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
GrantOption (right to buy) · Derivative | 44,325 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003627 · edgar.xml · derivative · entry 5 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,325 Underlying: Common shares · 44,325 shares Expires 2024-02-20 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 14,775 on 2/21/2015, 14,775 on 2/21/2016, and 14,775 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:19 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
GrantCommon shares without par value | 7,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003627 · edgar.xml · nonDerivative · entry 1 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,468 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:20 UTC |
Pavee Jean-YvesSenior Vice President
|
GrantOption (right to buy) · Derivative | 81,940 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003629 · edgar.xml · derivative · entry 1 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,940 Underlying: Common shares · 81,940 shares Expires 2024-02-20 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,314 on 2/21/2015, 27,313 on 2/21/2016, and 27,313 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:21 UTC |
Simhambhatla Murthy VSenior Vice President
|
GrantOption (right to buy) · Derivative | 112,668 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003630 · edgar.xml · derivative · entry 2 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,668 Underlying: Common shares · 112,668 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 37,556 on 2/21/2015, 37,556 on 2/21/2016, and 37,556 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:21 UTC |
Simhambhatla Murthy VSenior Vice President
|
GrantCommon shares without par value | 18,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003630 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,747 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:39 UTC |
White J. ScottSenior Vice President
|
GrantOption (right to buy) · Derivative | 92,183 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003636 · edgar.xml · derivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,183 Underlying: Common shares · 92,183 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,728 on 2/21/2015, 30,727 on 2/21/2016, and 30,728 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:39 UTC |
White J. ScottSenior Vice President
|
GrantCommon shares without par value | 15,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003636 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,043 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:23 UTC |
Landgraf John CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 154,953 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003631 · edgar.xml · derivative · entry 4 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,953 Underlying: Common Shares · 154,953 shares Expires 2024-02-20 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 51,651 on 2/21/2015, 51,651 on 2/21/2016, and 51,651 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:23 UTC |
Landgraf John CExecutive Vice President
|
GrantCommon shares without par value | 25,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003631 · edgar.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,731 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:41 UTC |
Warmuth Michael JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 107,793 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003639 · edgar.xml · derivative · entry 1 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,793 Underlying: Common shares · 107,793 shares Expires 2024-02-20 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 35,931 on 2/21/2015, 35,931 on 2/21/2016 and 35,931 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:49 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 727,699 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003644 · edgar.xml · derivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 727,699 Underlying: Common shares · 727,699 shares Expires 2024-02-20 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 242,567 on 2/21/2015, 242,566 on 2/21/2016, and 242,566 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:49 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantCommon shares without par value | 118,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003644 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,506,407 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:06 UTC |
Pavee Jean-YvesSenior Vice President
|
SaleCommon shares without par value | 489 | $38.97 | $19,053.89 |
DisclosureSEC source: 0001179110-14-003076 · edgar.xml · nonDerivative · entry 3 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,479 Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:06 UTC |
Pavee Jean-YvesSenior Vice President
|
Tax withholdingCommon shares without par value | 325 | $38.81 | $12,613.25 |
DisclosureSEC source: 0001179110-14-003076 · edgar.xml · nonDerivative · entry 2 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,968 Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:06 UTC |
Simhambhatla Murthy VSenior Vice President
|
Tax withholdingCommon Shares without par value | 306 | $38.81 | $11,875.86 |
DisclosureSEC source: 0001179110-14-003075 · edgar.xml · nonDerivative · entry 2 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,344 Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:06 UTC |
ALLEN HUBERT LExecutive Vice President
|
SaleCommon shares without par value | 333 | $39.07 | $13,008.65 |
DisclosureSEC source: 0001179110-14-003077 · edgar.xml · nonDerivative · entry 3 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,033 Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:06 UTC |
ALLEN HUBERT LExecutive Vice President
|
Tax withholdingCommon shares without par value | 346 | $38.81 | $13,428.26 |
DisclosureSEC source: 0001179110-14-003077 · edgar.xml · nonDerivative · entry 2 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,366 Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 23:54 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionOption(right to buy) · Derivative | 1,583 | $0.00 Strike: $35.03 | $0.00 |
DisclosureSEC source: 0001179110-14-003112 · edgar.xml · derivative · entry 6 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,583 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 23:54 UTC |
Landgraf John CExecutive Vice President
|
SaleCommon Shares without par value | 600 | $39.11 | $23,463.00 |
DisclosureSEC source: 0001179110-14-003112 · edgar.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,421 Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 23:54 UTC |
Landgraf John CExecutive Vice President
|
SaleCommon Shares without par value | 983 | $39.10 | $38,436.28 |
DisclosureSEC source: 0001179110-14-003112 · edgar.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,021 Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 23:54 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionCommon Shares without par value | 1,583 | $35.03 | $55,452.49 |
DisclosureSEC source: 0001179110-14-003112 · edgar.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 23:53 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 621 | $38.96 | $24,191.06 |
DisclosureSEC source: 0001179110-14-003110 · edgar.xml · nonDerivative · entry 7 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 1,067 F3 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his spouse. Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 23:53 UTC |
Contreras JaimeSenior Vice President
|
Tax withholdingCommon shares without par value | 126 | $38.81 | $4,890.06 |
DisclosureSEC source: 0001179110-14-003110 · edgar.xml · nonDerivative · entry 6 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 1,688 F3 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his spouse. Read SEC document |
| February 17, 2014 Filed Feb 19, 2014 22:06 UTC |
Pavee Jean-YvesSenior Vice President
|
Tax withholdingCommon shares without par value | 608 | $38.81 | $23,596.48 |
DisclosureSEC source: 0001179110-14-003076 · edgar.xml · nonDerivative · entry 1 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,293 Read SEC document |
| February 17, 2014 Filed Feb 19, 2014 22:06 UTC |
Simhambhatla Murthy VSenior Vice President
|
Tax withholdingCommon Shares without par value | 485 | $38.81 | $18,822.85 |
DisclosureSEC source: 0001179110-14-003075 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,650 Read SEC document |
| February 17, 2014 Filed Feb 19, 2014 22:06 UTC |
ALLEN HUBERT LExecutive Vice President
|
Tax withholdingCommon shares without par value | 395 | $38.81 | $15,329.95 |
DisclosureSEC source: 0001179110-14-003077 · edgar.xml · nonDerivative · entry 1 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,712 Read SEC document |
| February 17, 2014 Filed Feb 19, 2014 23:53 UTC |
Contreras JaimeSenior Vice President
|
Tax withholdingCommon shares without par value | 101 | $38.81 | $3,919.81 |
DisclosureSEC source: 0001179110-14-003110 · edgar.xml · nonDerivative · entry 5 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 1,814 Read SEC document |
| February 15, 2014 Filed Feb 19, 2014 23:53 UTC |
Contreras JaimeSenior Vice President
|
Tax withholdingCommon shares without par value | 151 | $38.81 | $5,860.31 |
DisclosureSEC source: 0001179110-14-003110 · edgar.xml · nonDerivative · entry 4 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 1,915 F3 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his spouse. Read SEC document |
| February 07, 2014 Filed Feb 11, 2014 22:05 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 21,972 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0001179110-14-002504 · edgar.xml · derivative · entry 6 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 21,972 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 07, 2014 Filed Feb 11, 2014 22:05 UTC |
Landgraf John CExecutive Vice President
|
SaleCommon Shares without par value | 11,572 | $36.96 | $427,701.12 |
DisclosureSEC source: 0001179110-14-002504 · edgar.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,421 Read SEC document |
| February 07, 2014 Filed Feb 11, 2014 22:05 UTC |
Landgraf John CExecutive Vice President
|
SaleCommon Shares without par value | 10,400 | $36.95 | $384,280.00 |
DisclosureSEC source: 0001179110-14-002504 · edgar.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,993 Read SEC document |
| February 07, 2014 Filed Feb 11, 2014 22:05 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionCommon Shares without par value | 21,972 | $32.16 | $706,529.43 |
DisclosureSEC source: 0001179110-14-002504 · edgar.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2014 Filed Mar 13, 2015 21:29 UTC |
Doyle Katherine C.Senior Vice President
|
SaleCommon shares without par value | 1 | $35.93 | $35.93 |
DisclosureSEC source: 0001179110-15-004891 · edgar.xml · nonDerivative · entry 3 Doyle Katherine C. · CIK 0001570003 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,432 Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 22:02 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
Exercise / conversionOption (right to buy) · Derivative | 1,546 | $0.00 Strike: $35.08 | $0.00 |
DisclosureSEC source: 0001179110-14-001871 · edgar.xml · derivative · entry 12 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,546 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 22:02 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
Exercise / conversionOption (right to buy) · Derivative | 5,715 | $0.00 Strike: $33.88 | $0.00 |
DisclosureSEC source: 0001179110-14-001871 · edgar.xml · derivative · entry 11 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,715 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 22:02 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
Exercise / conversionOption (right to buy) · Derivative | 2,137 | $0.00 Strike: $31.61 | $0.00 |
DisclosureSEC source: 0001179110-14-001871 · edgar.xml · derivative · entry 10 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,137 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 22:02 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
SaleCommon shares without par value | 1,192 | $36.21 | $43,162.32 |
DisclosureSEC source: 0001179110-14-001871 · edgar.xml · nonDerivative · entry 6 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,228 Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 22:02 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
SaleCommon shares without par value | 5,608 | $36.20 | $203,009.60 |
DisclosureSEC source: 0001179110-14-001871 · edgar.xml · nonDerivative · entry 5 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,420 Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 22:02 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
SaleCommon shares without par value | 2,598 | $36.19 | $94,021.62 |
DisclosureSEC source: 0001179110-14-001871 · edgar.xml · nonDerivative · entry 4 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,028 Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 22:02 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
Exercise / conversionCommon shares without par value | 1,546 | $35.08 | $54,233.68 |
DisclosureSEC source: 0001179110-14-001871 · edgar.xml · nonDerivative · entry 3 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 22:02 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
Exercise / conversionCommon shares without par value | 5,715 | $33.88 | $193,624.20 |
DisclosureSEC source: 0001179110-14-001871 · edgar.xml · nonDerivative · entry 2 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 22:02 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
Exercise / conversionCommon shares without par value | 2,137 | $31.61 | $67,546.51 |
DisclosureSEC source: 0001179110-14-001871 · edgar.xml · nonDerivative · entry 1 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2014 Filed Jan 31, 2014 22:01 UTC |
Warmuth Michael JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,923 | $0.00 Strike: $32.60 | $0.00 |
DisclosureSEC source: 0001179110-14-001634 · edgar.xml · derivative · entry 8 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,923 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 29, 2014 Filed Jan 31, 2014 22:01 UTC |
Warmuth Michael JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,404 | $0.00 Strike: $31.90 | $0.00 |
DisclosureSEC source: 0001179110-14-001634 · edgar.xml · derivative · entry 7 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,404 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 29, 2014 Filed Jan 31, 2014 22:01 UTC |
Warmuth Michael JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,103 | $0.00 Strike: $31.26 | $0.00 |
DisclosureSEC source: 0001179110-14-001634 · edgar.xml · derivative · entry 6 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,103 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 29, 2014 Filed Jan 31, 2014 22:01 UTC |
Warmuth Michael JExecutive Vice President
|
SaleCommon shares without par value | 11,430 | $36.21 | $413,832.29 |
DisclosureSEC source: 0001179110-14-001634 · edgar.xml · nonDerivative · entry 4 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,487 Read SEC document |
| January 29, 2014 Filed Jan 31, 2014 22:01 UTC |
Warmuth Michael JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,923 | $32.60 | $95,283.95 |
DisclosureSEC source: 0001179110-14-001634 · edgar.xml · nonDerivative · entry 3 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.